Stock Events

Stock Events

Vivos Therapeutics 

$1.18
18
+$0.09+8.26% Tuesday 20:00

Statistics

Day High
1.18
Day Low
1.09
52W High
7.95
52W Low
1.09
Volume
68,326
Avg. Volume
127,626
Mkt Cap
10.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
Next
-1.05
-0.83
-0.6
-0.38
Expected EPS
-0.45
Actual EPS
N/A

Financials

-74.09%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
30.06MRevenue
-22.27MNet Income

Analyst Ratings

$6.25Average Price Target
The highest estimate is 7.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VVOS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap9.99B
Align Technology is a direct competitor in the orthodontic market, offering clear aligner therapies that compete with Vivos' sleep apnea and orthodontic treatments.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its dental segment, offers a range of products that compete with Vivos' solutions in the dental and orthodontic market.
DENTSPLY Sirona
XRAY
Mkt Cap2.52B
Dentsply Sirona is a competitor in the dental supplies and equipment market, offering products that can be used in orthodontic and sleep apnea treatments.
Henry Schein
HSIC
Mkt Cap7.66B
Henry Schein is a distributor of healthcare products and services, including dental products that compete with Vivos Therapeutics' offerings.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the healthcare market by providing solutions that can overlap with Vivos' treatments in orthopedics and dental health.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a medical technology company that, while focusing on orthopedic products, competes in the broader healthcare market against Vivos Therapeutics.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical devices and therapies that compete with Vivos Therapeutics in areas such as sleep apnea treatment and healthcare solutions.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical is involved in musculoskeletal solutions, indirectly competing with Vivos by offering treatments that can affect patients' overall health, including aspects of sleep and orthopedic health.

About

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Show more...
CEO
Mr. R. Kirk Huntsman
Employees
109
Country
US
ISIN
US92859E2072

Listings

XNAS
US
VVOS
BOATS
BOATS
VVOS.BOATS

0 Comments

Share your thoughts

FAQ

What is Vivos Therapeutics stock price today?▼
The current price of VVOS is $1.18 USD — it has increased by +8.26% in the past 24 hours. Watch Vivos Therapeutics stock price performance more closely on the chart.
What is Vivos Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vivos Therapeutics stocks are traded under the ticker VVOS.
Is Vivos Therapeutics stock price growing?▼
VVOS stock has risen by +3.51% compared to the previous week, the month change is a -15.71% fall, over the last year Vivos Therapeutics has showed a -55.13% decrease.
What is Vivos Therapeutics market cap?▼
Today Vivos Therapeutics has the market capitalization of 10.61M
When is the next Vivos Therapeutics earnings date?▼
Vivos Therapeutics is going to release the next earnings report on May 18, 2026.
What is Vivos Therapeutics revenue for the last year?▼
Vivos Therapeutics revenue for the last year amounts to 30.06M USD.
What is Vivos Therapeutics net income for the last year?▼
VVOS net income for the last year is -22.27M USD.
How many employees does Vivos Therapeutics have?▼
As of April 01, 2026, the company has 109 employees.
In which sector is Vivos Therapeutics located?▼
Vivos Therapeutics operates in the Health Care sector.
When did Vivos Therapeutics complete a stock split?▼
The last stock split for Vivos Therapeutics was on October 27, 2023 with a ratio of 1:25.
Where is Vivos Therapeutics headquartered?▼
Vivos Therapeutics is headquartered in Littleton, US.